On March 23, 2010
Sanofi’s $1B Multaq Heart-Drug Mess Is Getting Worse — Quickly
The scale of Sanofi-Aventis (SNY)’s Multaq mess is starting to become apparent: The heart drug, hailed by the company as a €1 billion-plus blockbuster prior to its launch, may miss Wall Street sales estimates by as much as €1.3 billion.
…
0 Comments